Benzimidazole Synthesis via Formate Reduction and Cyclization

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current processes for preparing benzimidazole derivatives for treating neuropathic pain are inefficient, requiring protection/deprotection steps and complex procedures, which hinder industrial scalability and product purity.

Innovation Solution

A novel process involving the reduction and cyclization of specific intermediates using formate equivalents, eliminating the need for protection/deprotection steps and simplifying the synthesis to achieve high-purity benzimidazole derivatives in a shorter reaction time.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If conventional processes are used to prepare benzimidazole derivatives, then the product can be obtained, but the process requires protection/deprotection steps and complex procedures

Engineering Contradiction:
Improveprocess simplicityVSAvoidprocess complexity
Core Design Contradiction:
Ease of manufactureVSDevice complexity

Solution Approach 1:

The invention extracts and eliminates the unnecessary protection/deprotection steps from the conventional synthesis pathway. By using a direct cyclization approach with formate equivalents, the method removes these cumbersome intermediate steps while maintaining product yield and purity, thereby simplifying the overall manufacturing process

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention performs preliminary functionalization of the aromatic compound to introduce the necessary substituents before cyclization. This preliminary action allows the subsequent cyclization step to proceed directly to form the benzimidazole core without requiring protective groups, streamlining the synthesis pathway

Inventive Principle:
Principle #10Preliminary action

2Productivity

If conventional processes are used to prepare benzimidazole derivatives, then the product can be obtained, but the reaction time is extended

Engineering Contradiction:
Improvereaction efficiencyVSAvoidreaction time
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention implements a continuous one-pot reaction sequence where reduction and cyclization occur sequentially without isolation of intermediates. This continuous process eliminates time losses associated with workup and purification steps between reactions, significantly reducing total reaction time while maintaining high productivity

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The invention merges multiple reaction steps (reduction of nitro group and cyclization to form benzimidazole) into a single reaction vessel. By combining these steps with formate equivalents serving as both reducing agent and cyclization reagent, the method reduces overall reaction time and improves operational efficiency

Inventive Principle:
Principle #5Merging (Combining)

3Manufacturing precision

If conventional processes are used to prepare benzimidazole derivatives, then the product can be obtained, but purification by column chromatography is required

Engineering Contradiction:
Improveproduct purityVSAvoidpurification complexity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The reaction conditions are designed to inherently favor the formation of the desired benzimidazole product with high selectivity. The formate equivalents and catalyst system promote clean cyclization with minimal side reactions, allowing the product to be obtained in high purity without requiring complex chromatographic purification

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The invention optimizes reaction parameters including temperature, solvent selection, and catalyst loading to maximize product selectivity. By carefully controlling these parameters, the reaction produces the desired benzimidazole derivative with sufficient purity that simplifies downstream purification requirements

Inventive Principle:
Principle #35Parameter changes

4Productivity

If conventional processes are used to prepare benzimidazole derivatives, then the product can be obtained, but the process is not industrially advantageous

Engineering Contradiction:
Improveindustrial scalabilityVSAvoidprocess complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The invention segments the synthesis into two straightforward stages: (1) preliminary functionalization of aromatic substrate, and (2) one-pot reduction-cyclization. This segmentation creates a modular process that is easier to scale and control industrially compared to conventional multi-step sequences requiring multiple isolations and purifications

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The preliminary functionalization step prepares the aromatic compound with necessary substituents and leaving groups that enable direct cyclization. This preliminary action ensures that the main transformation can proceed efficiently in a single operation, making the overall process more suitable for industrial production

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The process enables the production of benzimidazole derivatives with high purity and yield in a simplified, industrially advantageous manner, avoiding the need for column chromatography purification and reducing reaction complexity.

Implementation Method 1

reducing a compound of formula (2)

Methodology Applied
Scientific EffectReduction: Reduction

Implementation Method 2

cyclizing the reduced product with a formate equivalent

Methodology Applied
Scientific EffectCyclization:

Data Source

PatentUS11242332B2Method for producing benzimidazole derivative
Publication Date: 2022.02.08 SUMITOMO PHARMA CO LTD
  • US11242332B2 patent drawing
  • US11242332B2 patent drawing
  • US11242332B2 patent drawing

AI summary

The present invention relates to a process to prepare a benzimidazole derivative useful as a medicament, an intermediate for preparing the medicament, and a process to prepare the intermediate.